Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is -74.27% vs 23.91% in Mar 2024
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
No Fixed Assets in the last few periods;
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2025 is 452.97% vs 569.12% in Mar 2024
Compare Balance Sheet Results of Kabra Drugs
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
23.71
17.16
6.55
38.17%
Share Warrants & Outstandings
Total Reserve
0.95
53.75
-52.80
-98.23%
Shareholder's Funds
24.65
78.19
-53.54
-68.47%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.00
40.44
-40.44
-100.00%
Secured Loans
0.00
40.44
-40.44
-100.00%
Unsecured Loans
0.00
0.00
0.00
0.00%
Deferred Tax Assets / Liabilities
0.00
1.77
-1.77
-100.00%
Other Long Term Liabilities
0.00
0.00
0.00
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.78
-0.78
-100.00%
Total Non-Current Liabilities
0.00
35.26
-35.26
-100.00%
Current Liabilities
Trade Payables
0.00
0.98
-0.98
-100.00%
Other Current Liabilities
0.14
0.00
0.14
0.00%
Short Term Borrowings
0.44
19.09
-18.65
-97.70%
Short Term Provisions
0.00
7.77
-7.77
-100.00%
Total Current Liabilities
0.57
27.84
-27.27
-97.95%
Total Liabilities
25.23
141.29
-116.06
-82.14%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
0.05
155.53
-155.48
-99.97%
Less: Accumulated Depreciation
0.01
70.65
-70.64
-99.99%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
0.04
84.88
-84.84
-99.95%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
12.84
-12.84
-100.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.00
0.04
-0.04
-100.00%
Long Term Loans & Advances
0.02
0.00
0.02
0.00%
Other Non Current Assets
0.00
0.21
-0.21
-100.00%
Total Non-Current Assets
0.07
97.97
-97.90
-99.93%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
0.00
7.79
-7.79
-100.00%
Sundry Debtors
0.60
11.21
-10.61
-94.65%
Cash and Bank
21.30
1.21
20.09
1,660.33%
Other Current Assets
0.00
0.76
-0.76
-100.00%
Short Term Loans and Advances
3.26
22.34
-19.08
-85.41%
Total Current Assets
25.16
43.31
-18.15
-41.91%
Net Current Assets (Including Current Investments)
24.59
15.48
9.11
58.85%
Total Current Assets Excluding Current Investments
25.16
43.31
-18.15
-41.91%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
25.23
141.29
-116.06
-82.14%
Contingent Liabilities
0.49
0.00
0.49
0.00%
Total Debt
0.44
44.07
-43.63
-99.00%
Book Value per share (adjusted)
10.40
41.32
-30.92
-74.83%
Annual - Borrowings
Borrowings 0.44 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -74.27% vs 23.91% in Mar 2024
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 0.04 Cr
in Mar 2025Figures in Cr
No Fixed Assets in the last few periods;
Annual - Investments
No Investments in the last few periods
No Investments in the last few periods;
Annual - Current Assets
Current Assets 25.16 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 452.97% vs 569.12% in Mar 2024






